Literature DB >> 11373886

Radiotherapy for brain metastases.

P J Hoskin1, M Brada.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11373886     DOI： 10.1053/clon.2001.9226

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  7 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 2.  Brain metastases: treatment options to improve outcomes.

Authors:  Phillip Davey
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy.

Authors:  Farkhad Manapov
Journal:  J Neurooncol       Date:  2009-12-15       Impact factor: 4.130

4.  Management of Brain Metastases.

Authors:  Suriya A. Jeyapalan; Tracy Batchelor
Journal:  Curr Treat Options Neurol       Date:  2004-07       Impact factor: 3.598

Review 5.  Evidence of elemene injection combined radiotherapy in lung cancer treatment among patients with brain metastases: A systematic review and meta-analysis.

Authors:  Xutao Jiang; Tesfaldet Habtemariam Hidru; Zhuo Zhang; Yu Bai; Lingchao Kong; Xiaofeng Li
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival.

Authors:  Kartick Rastogi; Sandeep Bhaskar; Shivani Gupta; Sandeep Jain; Daleep Singh; Pawan Kumar
Journal:  Indian J Palliat Care       Date:  2018 Jul-Sep

7.  Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.

Authors:  Paula Mulvenna; Matthew Nankivell; Rachael Barton; Corinne Faivre-Finn; Paula Wilson; Elaine McColl; Barbara Moore; Iona Brisbane; David Ardron; Tanya Holt; Sally Morgan; Caroline Lee; Kathryn Waite; Neil Bayman; Cheryl Pugh; Benjamin Sydes; Richard Stephens; Mahesh K Parmar; Ruth E Langley
Journal:  Lancet       Date:  2016-09-04       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.